Clinical Considerations of Isavuconazole Administration in High-Risk Hematological Patients: A Single-Center 5-Year Experience.

Ilona KronigStavroula Masouridi-LevratYves ChalandonEmmanouil GlampedakisNathalie VernazChristian Van DeldenDionysios Neofytos

Published in: Mycopathologia (2021)

Isavuconazole is a safe and reliable antifungal agent in complex hematological patients, with relatively low hepatotoxicity and QTc interval shortening properties.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
patient reported outcomes